Malaysia: MDA Opens Public Consultation on Updated Verification Pathway Draft Guidance

The Medical Device Authority (MDA) has announced a public consultation on updated Third Edition draft guidance documents (MDA/GD/0068 and MDA/GD/0070) to obtain stakeholder feedback on the proposed verification pathway guidelines.

The updated drafts are:

  1. MDA/GD/0068 – Conformity Assessment Body (CAB) Guide for Conducting Conformity Assessment by Way of Verification (PDF)
  2. MDA/GD/0070 – Establishment Guide to Medical Device Registration Submission in MeDC@St Through Conformity Assessment by Way of Verification Process (PDF)

The revisions provide an indication of MDA’s proposed approach to conformity assessment, registration submissions, Quality Management System documentation, technical evidence, and applicable fees under the verification pathway.

Read the MDA announcement here:
https://portal.mda.gov.my/index.php/announcement/1865-announcement-public-consultation-on-updated-draft-guidance-documents-third-edition

Purpose of the Draft Update

To propose revisions to the verification pathway guidance for Conformity Assessment Bodies and establishments in Malaysia, and to gather stakeholder feedback.

The proposed changes also align the guidance with MDA Circular Letter No. 2 of 2025: Conformity Assessment Procedures for Medical Devices Approved by Recognised Countries.

Key Updates to MDA/GD/0068

Conformity Assessment Body Guide for Conducting Conformity Assessment by Way of Verification

SectionProposed Change
IntroductionUpdated to refer to MDA Circular Letter No. 2 of 2025.
Scope and ApplicationUpdated to refer to MDA Circular Letter No. 2 of 2025.
Conformity Assessment ProcedureUpdated to refer to MDA Circular Letter No. 2 of 2025.
Appendix 2: Conformity Assessment Elements Review and Verification Criteria for Class B, C and D Initial Certification and RecertificationAdds a statement stating that pre-clinical studies should be conducted in accredited laboratories. A note is also added stating that clinical performance studies for in-vitro medical devices should be conducted in accredited laboratories.

Key Updates to MDA/GD/0070

Establishment Guide to Medical Device Registration Submission in MeDC@St Through Conformity Assessment by Way of Verification

SectionProposed Change
IntroductionUpdated to refer to MDA Circular Letter No. 2 of 2025.
Scope and ApplicationUpdated to refer to MDA Circular Letter No. 2 of 2025.
Conformity Assessment Procedure / MeDC@St for New and Re-Registration ApplicationsUpdated to refer to MDA Circular Letter No. 2 of 2025.
Table of FeesAdds application and registration fees for Class A medical devices.
Class A Medical Device Registration Application in MeDC@St for New and Re-Registration ApplicationUnder Section 6 (Manufacturer Information), provide updated copies of the legal manufacturer’s ISO 13485 certificates or updated documentation for another acceptable quality management system (QMS). Acceptable alternatives include MDSAP, US FDA Quality Systems Regulations and Japan MHLW Ordinance 169. ISO 9001 is acceptable only for a Class A empty gas cylinder.
Annex 4: Class B, C and D Verification Submission GuidePre-clinical studies should be conducted in the accredited laboratories in Section 4 Common Submission Dossier Template (CSDT) (Pre-clinical Studies)

Note:
Clinical performances should be conducted in the accredited laboratories in Section 4: Common Submission Dossier Template (CSDT).(Clinical performance for in-vitro medical devices)

Included Application and Registration Fees for Class A Medical Device

ClassApplication Fee (RM)Registration Fee (RM)
Class A500750
Class B2501,000
Class C5002,000
Class D7003,000
Class A medical device containing a medicinal product7005,000

Applicable Laws and Regulations

The draft guidance documents should be read together with:

  1. Medical Device Act 2012 (Act 737)
  2. Medical Device Regulations 2012
  3. MDA Circular Letter No. 2 of 2025: Conformity Assessment Procedures for Medical Devices Approved by Recognised Countries

Implications to Clients

Manufacturers, Authorized Representatives, importers, distributors and CABs are encouraged to review how the proposed changes may affect their current or planned registration projects and submit any relevant feedback to MDA during the public consultation period.

Effective Date

To be announced upon final issuance of the guidance documents.

For Inquiries

For inquiries or support regarding medical device regulatory requirements in Malaysia, please contact sales@andamanmed.com.

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo